Multivitamins have better evidence for brain health than NAD+ boosters, but neither has been tested head-to-head in humans, and neither is proven to prevent cognitive decline in people with normal brain function. Multivitamins show measurable memory benefits in long-term studies (3+ years) of older adults, while NAD+ precursors like NMN and NR successfully raise blood NAD+ levels but have failed to improve cognition in healthy people and remain studied only in disease settings. The comparison is lopsided because the research pathways are different: multivitamins are established interventions tested for general cognitive aging, while NAD+ boosters are still-experimental compounds tested in Alzheimer's and Parkinson's trials. If you are considering either, the practical question is not which is better in a direct sense, but whether the evidence supports your specific situation.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What multivitamin research actually shows
- What NAD+ booster research shows instead
- No direct comparison exists—and the pathways are different
- The evidence gap for true prevention
- How to interpret "brain health" claims
- Frequently Asked Questions
What multivitamin research actually shows
A meta-analysis of 5,000+ older adults found that multivitamin supplementation lasting 3 or more years improved memory by an amount equivalent to slowing roughly 3 years of age-related cognitive decline; shorter trials (1 year or less) showed no benefit. This is the clearest evidence base for either intervention. The memory gains were modest but real and showed up only in longer studies, meaning multivitamins are not a quick fix.
Researchers conducting these trials noted that benefits may have been concentrated in people who started with nutrient inadequacy—those already eating a brain-healthy diet rich in B vitamins, folate, and minerals were unlikely to see added benefit. This is important: multivitamins appear to help primarily by correcting a deficit, not by boosting normal function beyond its natural level. The evidence base rests on large randomized controlled trials enrolling 3,500+ older adults, making it far larger than any NAD+ study.
What NAD+ booster research shows instead
Oral NAD+ precursors—specifically nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN)—do successfully raise circulating NAD+ by 130–150%, yet they have not improved cognition in healthy older adults who took them. Even after 12 weeks of daily NMN or NR, scores on standardized cognitive tests like the Montreal Cognitive Assessment remained unchanged.
NAD+ boosters are currently studied only in people with established disease—Parkinson's, Alzheimer's, or long COVID—not in cognitively normal older adults. Phase I and II trials are measuring whether NAD+ compounds improve biomarkers (like brain imaging) or slow disease progression, not whether they enhance memory in healthy people. This is a crucial distinction: there are no published efficacy trials testing NAD+ supplements as a cognitive preventive in people without cognitive impairment.
No direct comparison exists—and the pathways are different
A 2026 systematic review of 113 studies identified only 33 human intervention trials on NAD+ compounds and found zero head-to-head comparisons with multivitamins. The evidence gap is not a gap in research quality; it reflects different research trajectories. Multivitamins have been studied as general preventive health measures for decades. NAD+ boosters are newer experimental drugs being tested as disease treatments.
Additionally, multivitamin and NAD+ pathways in the brain do not overlap. Multivitamin benefits appear to come from correcting B-vitamin and folate insufficiency. NAD+ works through mitochondrial and sirtuin-dependent cellular pathways. These are distinct mechanisms, so evidence that one works does not tell you whether the other will. You cannot assume that because multivitamins help memory, NAD+ boosters will—or vice versa.
The evidence gap for true prevention
Both interventions lack proof that they prevent cognitive decline in truly cognitively normal older adults. Multivitamin trials enrolled people aged 60+ and followed them for 3+ years, but multivitamin benefits were concentrated in those with baseline nutrient inadequacy.
NAD+ trials either studied people with long COVID, mild cognitive impairment, or established neurodegenerative disease—not low-risk healthy populations. This matters because the question "will this prevent my cognitive decline?" is different from "will this slow decline if I already have it?" The evidence supports multivitamins for slowing age-related memory changes in people who lack sufficient micronutrients, and NAD+ for testing in neurodegenerative disease. Neither is proven as a preventive strategy for someone with normal brain function and adequate nutrition.
How to interpret "brain health" claims
When you see NAD+ boosters marketed for brain health or cognitive support, you are reading marketing based on animal studies and mechanistic hypotheses, not human evidence. The state of NAD+ research in human brain is incomplete—it is not yet clear whether oral NAD+ precursors achieve sufficient concentration in the brain to have an effect. In contrast, multivitamin benefits are observed in actual people over years, measured with standard cognitive tests.
Multivitamins also carry minimal risk if you tolerate them and have no contraindications with your medications; NAD+ boosters have a smaller safety database because they are newer. If you have a nutrient deficiency (detectable via blood work for B12, folate, or other micronutrients), multivitamins may help. If you have a neurodegenerative disease, NAD+ compounds may be worth discussing with a neurologist as part of a clinical trial. If you have normal cognition and adequate nutrition, neither has evidence to offer.
Frequently Asked Questions
Should I take multivitamins to protect my brain?
Only if you have a nutrient deficiency. Benefits appear to come from correcting insufficiency (low B vitamins, folate, minerals), not from boosting normal levels. A blood test can tell you whether you have a gap. If you eat a varied diet with vegetables, whole grains, and protein, you likely do not need them for cognitive protection.
Could NAD+ boosters work even if they haven't been tested in healthy older adults yet?
Possibly—but "could work" is not evidence that they do. They successfully raise blood NAD+ levels, yet they have not improved memory or thinking in the studies that measured it. Until they are tested in people with normal cognition, you are betting on mechanism, not on observed results.
What if I have mild cognitive impairment or early Alzheimer's?
NAD+ compounds are in early-stage clinical trials for these conditions. Multivitamins have not been tested specifically in people with cognitive impairment. Talk to your neurologist about whether enrollment in a NAD+ trial makes sense for you, or whether correcting any micronutrient deficiency is worthwhile.
Do I need to choose one or the other?
Not necessarily. If you have a deficiency, correcting it with multivitamins is evidence-based and low-risk. NAD+ boosters are not proven to interfere with that. Your decision depends on your own nutrient status, cognitive baseline, and any diagnosed neurological condition—not on choosing a supplement based on marketing or mechanism alone.
